In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through ...

Olympus has engaged a global executive recruitment firm to assist a board search committee evaluating CEO candidates.

Over the past 12 months, a number of medtech companies at various stages hauled in significant funding rounds to support ...

CMS announced a proposed decision to cover transcatheter tricuspid valve replacement (TTVR) for Medicare beneficiaries.

Roivios announced that it received FDA investigational device exemption (IDE) approval to conduct a trial for its renal ...

With approval, the company can begin commercializing the device in the U.S. in 2025.